Brain Canada and the ALS Society of Canada are pleased to announce the continuation of the Discovery Grant Program. The purpose of the 2023 Discovery Grant Program is to invest in the best possible projects that are focused on identifying causes of, or treatments for ALS and/or related neurological diseases, including primary lateral sclerosis, progressive muscular atrophy, and ALS/FTLD (frontotemporal lobar dementia), or research focused on avenues to maximize function, minimize disability and optimize quality of life through symptom management, and support to persons or families living with ALS.

Please refer to the Terms of Reference for additional details.